O	O	0	9	Induction	Induction	B-NP	NN	O	12	SUB	O
O	O	10	12	of	of	B-PP	IN	O	1	NMOD	O
O	O	13	24	endothelial	endothelial	B-NP	JJ	B-protein	7	NMOD	B-protein
O	O	25	29	cell	cell	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	30	37	surface	surface	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	38	46	adhesion	adhesion	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	47	56	molecules	molecule	I-NP	NNS	I-protein	2	PMOD	I-protein
O	O	57	59	by	by	B-PP	IN	O	1	NMOD	O
O	O	60	65	tumor	tumor	B-NP	NN	B-protein	11	NMOD	B-protein
O	O	66	74	necrosis	necrosis	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	75	81	factor	factor	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	82	84	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	85	92	blocked	block	I-VP	VBN	O	12	VC	O
O	O	93	95	by	by	B-PP	IN	O	13	VMOD	O
O	O	96	103	protein	protein	B-NP	NN	O	18	NMOD	O
T7	B-Entity	104	112	tyrosine	tyrosine	I-NP	NN	O	18	NMOD	O
O	O	113	124	phosphatase	phosphatase	I-NP	NN	O	18	NMOD	O
O	O	125	135	inhibitors	inhibitor	I-NP	NNS	O	14	PMOD	O
O	O	135	136	:	:	O	:	O	12	P	O
O	O	137	141	role	role	B-NP	NN	O	12	VMOD	O
O	O	142	144	of	of	B-PP	IN	O	20	NMOD	O
O	O	145	148	the	the	B-NP	DT	O	29	NMOD	O
T8	B-Entity	149	156	nuclear	nuclear	I-NP	JJ	O	29	NMOD	O
T8	I-Entity	157	170	transcription	transcription	I-NP	NN	O	29	NMOD	O
T8	I-Entity	171	177	factor	factor	I-NP	NN	O	29	NMOD	O
T9	I-Entity	178	180	NF	NF	I-NP	NN	B-protein	29	NMOD	B-protein
T9	I-Entity	180	181	-	-	B-NP	HYPH	I-protein	29	NMOD	I-protein
T9	I-Entity	181	186	kappa	kappa	I-NP	NN	I-protein	29	NMOD	I-protein
T9	I-Entity	187	188	B	B	I-NP	NN	I-protein	21	PMOD	I-protein
O	O	188	189	.	.	O	.	O	12	P	O

O	O	191	197	Recent	Recent	B-NP	JJ	O	2	NMOD	O
O	O	198	205	studies	study	I-NP	NNS	O	6	SUB	O
O	O	206	210	from	from	B-PP	IN	O	2	NMOD	O
O	O	211	214	our	our	B-NP	PRP$	O	5	NMOD	O
O	O	215	225	laboratory	laboratory	I-NP	NN	O	3	PMOD	O
O	O	226	230	have	have	B-VP	VBP	O	0	ROOT	O
O	O	231	240	indicated	indicate	I-VP	VBN	O	6	VC	O
O	O	241	245	that	that	B-SBAR	IN	O	7	VMOD	O
O	O	246	253	protein	protein	B-NP	NN	B-protein	11	NMOD	B-protein
T10	B-Entity	254	262	tyrosine	tyrosine	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	263	274	phosphatase	phosphatase	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	275	276	(	(	O	(	O	14	DEP	O
O	O	276	282	PTPase	PTPase	B-NP	NN	B-protein	14	DEP	B-protein
O	O	282	283	)	)	O	)	O	11	NMOD	O
O	O	284	294	inhibitors	inhibitor	B-NP	NNS	O	16	SUB	O
O	O	295	298	can	can	B-VP	MD	O	8	SBAR	O
O	O	299	303	down	down	I-VP	RB	O	18	VMOD	O
O	O	303	304	-	-	I-VP	HYPH	O	16	VMOD	O
O	O	304	312	modulate	modulate	I-VP	VB	O	16	VC	O
O	O	313	316	the	the	B-NP	DT	O	23	NMOD	O
O	O	317	322	tumor	tumor	I-NP	NN	B-protein	23	NMOD	B-protein
O	O	323	331	necrosis	necrosis	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	332	338	factor	factor	I-NP	NN	I-protein	29	NMOD	I-protein
O	O	339	340	(	(	O	(	O	26	DEP	O
O	O	340	343	TNF	TNF	B-NP	NN	B-protein	26	DEP	B-protein
O	O	343	344	)	)	O	)	O	23	NMOD	O
O	O	344	345	-	-	O	HYPH	O	23	P	O
O	O	345	353	mediated	mediate	B-NP	VBN	O	29	NMOD	O
O	O	354	364	activation	activation	I-NP	NN	O	19	OBJ	O
O	O	365	367	of	of	B-PP	IN	O	29	NMOD	O
O	O	368	371	the	the	B-NP	DT	O	38	NMOD	O
T11	B-Entity	372	379	nuclear	nuclear	I-NP	JJ	O	38	NMOD	O
T11	I-Entity	380	393	transcription	transcription	I-NP	NN	O	38	NMOD	O
T11	I-Entity	394	400	factor	factor	I-NP	NN	O	38	NMOD	O
T12	I-Entity	401	403	NF	NF	I-NP	NN	B-protein	38	NMOD	B-protein
T12	I-Entity	403	404	-	-	B-NP	HYPH	I-protein	38	NMOD	I-protein
T12	I-Entity	404	409	kappa	kappa	I-NP	NN	I-protein	38	NMOD	I-protein
T12	I-Entity	410	411	B	B	I-NP	NN	I-protein	30	PMOD	I-protein
O	O	412	414	in	in	B-PP	IN	O	19	VMOD	O
O	O	415	417	ML	ML	B-NP	NN	B-cell_line	42	NMOD	B-cell_line
O	O	417	418	-	-	B-NP	HYPH	I-cell_line	42	NMOD	I-cell_line
O	O	418	420	1a	1a	I-NP	NN	I-cell_line	47	NMOD	I-cell_line
O	O	420	421	,	,	O	,	O	47	P	O
O	O	422	423	a	a	B-NP	DT	O	47	NMOD	O
O	O	424	433	monocytic	monocytic	I-NP	JJ	B-cell_line	47	NMOD	B-cell_line
O	O	434	438	cell	cell	I-NP	NN	I-cell_line	47	NMOD	I-cell_line
O	O	439	443	line	line	I-NP	NN	I-cell_line	39	PMOD	I-cell_line
O	O	444	445	(	(	O	(	O	64	DEP	O
O	O	445	450	Singh	Singh	B-NP	NNP	O	51	NMOD	O
O	O	451	454	and	and	O	CC	O	51	NMOD	O
O	O	455	463	Aggarwal	Aggarwal	B-NP	NNP	O	63	NMOD	O
O	O	463	464	,	,	O	,	O	63	P	O
O	O	465	466	J	J	B-NP	NNP	O	55	NMOD	O
O	O	466	467	.	.	I-NP	.	O	55	P	O
O	O	468	472	Biol	Biol	I-NP	NNP	O	57	NMOD	O
O	O	472	473	.	.	I-NP	.	O	57	P	O
O	O	474	478	Chem	Chem	I-NP	NNP	O	63	NMOD	O
O	O	478	479	.	.	I-NP	.	O	63	P	O
O	O	480	484	1995	1995	I-NP	CD	O	63	NMOD	O
O	O	484	485	:	:	O	:	O	63	P	O
O	O	486	489	270	270	B-NP	CD	O	63	NMOD	O
O	O	489	490	:	:	O	:	O	63	P	O
O	O	491	496	10631	10631	B-NP	CD	O	64	DEP	O
O	O	496	497	)	)	O	)	O	6	VMOD	O
O	O	497	498	.	.	O	.	O	6	P	O

O	O	499	504	Since	Since	B-SBAR	IN	O	33	VMOD	O
O	O	505	508	TNF	TNF	B-NP	NN	B-protein	3	SUB	B-protein
O	O	509	511	is	be	B-VP	VBZ	O	20	VMOD	O
O	O	512	515	one	one	B-NP	CD	O	3	PRD	O
O	O	516	518	of	of	B-PP	IN	O	4	NMOD	O
O	O	519	522	the	the	B-NP	DT	O	8	NMOD	O
O	O	523	528	major	major	I-NP	JJ	O	8	NMOD	O
O	O	529	537	inducers	inducer	I-NP	NNS	O	5	PMOD	O
O	O	538	540	of	of	B-PP	IN	O	8	NMOD	O
O	O	541	548	various	various	B-NP	JJ	O	9	PMOD	O
O	O	549	557	adhesion	adhesion	I-NP	NN	B-protein	12	NMOD	B-protein
O	O	558	567	molecules	molecule	I-NP	NNS	I-protein	10	NMOD	I-protein
O	O	568	570	in	in	B-PP	IN	O	8	NMOD	O
O	O	571	576	human	human	B-NP	JJ	B-cell_type	16	NMOD	B-cell_type
O	O	577	588	endothelial	endothelial	I-NP	JJ	I-cell_type	16	NMOD	I-cell_type
O	O	589	594	cells	cell	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	595	598	and	and	O	CC	O	20	VMOD	O
O	O	599	604	their	their	B-NP	PRP$	O	19	NMOD	O
O	O	605	615	expression	expression	I-NP	NN	O	20	SUB	O
O	O	616	618	is	be	B-VP	VBZ	O	1	SBAR	O
O	O	619	624	known	know	I-VP	VBN	O	20	VC	O
O	O	625	627	to	to	I-VP	TO	O	23	VMOD	O
O	O	628	635	require	require	I-VP	VB	O	21	VMOD	O
O	O	636	639	the	the	B-NP	DT	O	25	NMOD	O
O	O	640	650	activation	activation	I-NP	NN	O	23	OBJ	O
O	O	651	653	of	of	B-PP	IN	O	25	NMOD	O
T13	B-Entity	654	656	NF	NF	B-NP	NN	B-protein	30	NMOD	B-protein
T13	I-Entity	656	657	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T13	I-Entity	657	662	kappa	kappa	I-NP	NN	I-protein	30	NMOD	I-protein
T13	I-Entity	663	664	B	B	I-NP	NN	I-protein	26	PMOD	I-protein
O	O	664	665	,	,	O	,	O	33	P	O
O	O	666	668	we	we	B-NP	PRP	O	33	SUB	O
O	O	669	677	examined	examine	B-VP	VBD	O	0	ROOT	O
O	O	678	681	the	the	B-NP	DT	O	35	NMOD	O
O	O	682	688	effect	effect	I-NP	NN	O	33	OBJ	O
O	O	689	691	of	of	B-PP	IN	O	35	NMOD	O
O	O	692	698	PTPase	PTPase	B-NP	NN	B-protein	38	NMOD	B-protein
O	O	699	709	inhibitors	inhibitor	I-NP	NNS	O	36	PMOD	O
O	O	710	712	on	on	B-PP	IN	O	35	NMOD	O
O	O	713	716	the	the	B-NP	DT	O	44	NMOD	O
O	O	717	720	TNF	TNF	I-NP	NN	B-protein	44	NMOD	B-protein
O	O	720	721	-	-	B-VP	HYPH	O	44	NMOD	O
O	O	721	729	mediated	mediate	B-NP	VBN	O	44	NMOD	O
O	O	730	739	induction	induction	I-NP	NN	O	39	PMOD	O
O	O	740	742	of	of	B-PP	IN	O	44	NMOD	O
T1	B-Protein	743	756	intracellular	intracellular	B-NP	JJ	B-protein	48	NMOD	B-protein
T1	I-Protein	757	765	adhesion	adhesion	I-NP	NN	I-protein	48	NMOD	I-protein
T1	I-Protein	766	774	molecule	molecule	I-NP	NN	I-protein	50	NMOD	I-protein
T1	I-Protein	775	776	(	(	O	(	O	50	NMOD	O
T1	I-Protein	776	780	ICAM	ICAM	B-NP	NN	O	70	NMOD	O
T1	I-Protein	780	781	)	)	O	)	O	50	NMOD	O
T1	I-Protein	781	782	-	-	B-NP	HYPH	O	50	P	O
T1	I-Protein	782	783	1	1	I-NP	CD	O	50	NMOD	O
O	O	783	784	,	,	O	,	O	70	P	O
T2	B-Protein	785	793	vascular	vascular	B-NP	JJ	B-protein	58	NMOD	B-protein
T2	I-Protein	794	798	cell	cell	I-NP	NN	I-protein	58	NMOD	I-protein
T2	I-Protein	799	807	adhesion	adhesion	I-NP	NN	I-protein	58	NMOD	I-protein
T2	I-Protein	808	816	molecule	molecule	I-NP	NN	I-protein	70	NMOD	I-protein
T2	I-Protein	817	818	(	(	O	(	O	61	DEP	O
T2	I-Protein	818	822	VCAM	VCAM	B-NP	NN	B-protein	61	DEP	B-protein
T2	I-Protein	822	823	)	)	O	)	O	58	NMOD	O
T2	I-Protein	823	824	-	-	B-NP	HYPH	O	58	P	O
T2	I-Protein	824	825	1	1	I-NP	CD	O	58	NMOD	O
O	O	826	829	and	and	O	CC	O	70	NMOD	O
T3	B-Protein	830	841	endothelial	endothelial	B-NP	JJ	B-protein	70	NMOD	B-protein
T3	I-Protein	842	851	leukocyte	leukocyte	I-NP	NN	I-protein	70	NMOD	I-protein
T3	I-Protein	852	860	adhesion	adhesion	I-NP	NN	I-protein	70	NMOD	I-protein
T3	I-Protein	861	869	molecule	molecule	I-NP	NN	I-protein	70	NMOD	I-protein
T3	I-Protein	870	871	(	(	O	(	I-protein	70	NMOD	I-protein
T3	I-Protein	871	875	ELAM	ELAM	B-NP	NN	I-protein	45	PMOD	I-protein
T3	I-Protein	875	876	)	)	O	)	I-protein	70	NMOD	I-protein
T3	I-Protein	876	877	-	-	B-NP	HYPH	I-protein	70	P	I-protein
T3	I-Protein	877	878	1	1	I-NP	CD	I-protein	70	NMOD	I-protein
O	O	878	879	.	.	O	.	O	33	P	O

O	O	880	884	Like	Like	B-PP	IN	O	18	VMOD	O
O	O	885	887	ML	ML	B-NP	NN	B-cell_line	4	NMOD	B-cell_line
O	O	887	888	-	-	B-NP	HYPH	I-cell_line	4	NMOD	I-cell_line
O	O	888	890	1a	1a	I-NP	NN	I-cell_line	1	PMOD	I-cell_line
O	O	890	891	,	,	O	,	O	18	P	O
O	O	892	897	human	human	B-NP	JJ	B-cell_type	10	NMOD	B-cell_type
O	O	898	904	dermal	dermal	I-NP	JJ	I-cell_type	10	NMOD	I-cell_type
O	O	905	916	microvessel	microvessel	I-NP	NN	I-cell_type	10	NMOD	I-cell_type
O	O	917	928	endothelial	endothelial	I-NP	JJ	I-cell_type	10	NMOD	I-cell_type
O	O	929	934	cells	cell	I-NP	NNS	I-cell_type	18	SUB	I-cell_type
O	O	935	936	(	(	O	(	O	13	DEP	O
O	O	936	940	MVEC	MVEC	B-NP	NNS	B-cell_line	13	DEP	B-cell_line
O	O	940	941	)	)	O	)	O	10	NMOD	O
O	O	942	949	treated	treat	B-VP	VBN	O	10	NMOD	O
O	O	950	954	with	with	B-PP	IN	O	14	VMOD	O
O	O	955	958	TNF	TNF	B-NP	NN	B-protein	15	PMOD	B-protein
O	O	959	966	rapidly	rapidly	B-ADVP	RB	O	18	VMOD	O
O	O	967	976	activated	activate	B-VP	VBD	O	31	VMOD	O
O	O	977	978	(	(	O	(	O	23	DEP	O
O	O	978	984	within	within	B-PP	IN	O	23	DEP	O
O	O	985	987	30	30	B-NP	CD	O	22	NMOD	O
O	O	988	991	min	min	I-NP	NN	O	20	PMOD	O
O	O	991	992	)	)	O	)	O	18	VMOD	O
T14	B-Entity	993	995	NF	NF	B-NP	NN	B-protein	27	NMOD	B-protein
T14	I-Entity	995	996	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
T14	I-Entity	996	1001	kappa	kappa	I-NP	NN	I-protein	27	NMOD	I-protein
T14	I-Entity	1002	1003	B	B	I-NP	NN	I-protein	18	OBJ	I-protein
O	O	1003	1004	;	;	O	:	O	18	P	O
O	O	1005	1009	this	this	B-NP	DT	O	30	NMOD	O
O	O	1010	1016	effect	effect	I-NP	NN	O	31	SUB	O
O	O	1017	1020	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1021	1031	completely	completely	I-VP	RB	O	31	VMOD	O
O	O	1032	1041	abolished	abolish	I-VP	VBN	O	31	VC	O
O	O	1042	1044	by	by	B-PP	IN	O	33	VMOD	O
O	O	1045	1047	co	co	B-NP	AFX	O	37	NMOD	O
O	O	1047	1048	-	-	I-NP	HYPH	O	37	NMOD	O
O	O	1048	1057	treatment	treatment	I-NP	NN	O	34	PMOD	O
O	O	1058	1062	with	with	B-PP	IN	O	37	NMOD	O
O	O	1063	1075	phenylarsine	phenylarsine	B-NP	NN	O	40	NMOD	O
O	O	1076	1081	oxide	oxide	I-NP	NN	O	47	NMOD	O
O	O	1082	1083	(	(	O	(	O	43	DEP	O
O	O	1083	1086	PAO	PAO	B-NP	NN	O	43	DEP	O
O	O	1086	1087	)	)	O	)	O	40	NMOD	O
O	O	1087	1088	,	,	O	,	O	47	P	O
O	O	1089	1090	a	a	B-NP	DT	O	47	NMOD	O
O	O	1091	1099	specific	specific	I-NP	JJ	O	47	NMOD	O
O	O	1100	1109	inhibitor	inhibitor	I-NP	NN	O	38	PMOD	O
O	O	1110	1112	of	of	B-PP	IN	O	47	NMOD	O
O	O	1113	1119	PTPase	PTPase	B-NP	NN	B-protein	48	PMOD	B-protein
O	O	1119	1120	.	.	O	.	O	31	P	O

O	O	1121	1124	The	The	B-NP	DT	O	2	NMOD	O
O	O	1125	1134	induction	induction	I-NP	NN	O	0	ROOT	O
O	O	1135	1137	of	of	B-PP	IN	O	2	NMOD	O
T4	B-Protein	1138	1142	ICAM	ICAM	B-NP	NN	B-protein	5	NMOD	B-protein
T4	I-Protein	1142	1143	-	-	B-NP	HYPH	I-protein	20	VMOD	I-protein
T4	I-Protein	1143	1144	1	1	I-NP	CD	I-protein	5	NMOD	I-protein
O	O	1144	1145	,	,	O	,	O	20	P	O
T5	B-Protein	1146	1150	VCAM	VCAM	B-NP	NN	B-protein	9	NMOD	B-protein
T5	I-Protein	1150	1151	-	-	B-NP	HYPH	O	20	SUB	O
T5	I-Protein	1151	1152	1	1	I-NP	CD	O	9	NMOD	O
O	O	1152	1153	,	,	O	,	O	14	P	O
O	O	1154	1157	and	and	O	CC	O	14	NMOD	O
T6	B-Protein	1158	1162	ELAM	ELAM	B-NP	NN	B-protein	14	NMOD	B-protein
T6	I-Protein	1162	1163	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T6	I-Protein	1163	1164	1	1	I-NP	CD	I-protein	14	NMOD	I-protein
O	O	1165	1167	by	by	B-PP	IN	O	14	NMOD	O
O	O	1168	1171	TNF	TNF	B-NP	NN	B-protein	16	PMOD	B-protein
O	O	1172	1174	in	in	B-PP	IN	O	9	NMOD	O
O	O	1175	1179	MVEC	MVEC	B-NP	NNS	B-cell_line	18	PMOD	B-cell_line
O	O	1180	1188	occurred	occur	B-VP	VBD	O	3	SBAR	O
O	O	1189	1195	within	within	B-PP	IN	O	20	VMOD	O
O	O	1196	1197	6	6	B-NP	CD	O	23	NMOD	O
O	O	1198	1199	h	h	I-NP	NN	O	21	PMOD	O
O	O	1200	1203	and	and	O	CC	O	20	VMOD	O
O	O	1204	1207	was	be	B-VP	VBD	O	20	VMOD	O
O	O	1208	1212	also	also	B-ADVP	RB	O	25	VMOD	O
O	O	1213	1223	completely	completely	B-VP	RB	O	30	VMOD	O
O	O	1224	1228	down	down	I-VP	RB	O	27	AMOD	O
O	O	1228	1229	-	-	I-VP	HYPH	O	27	AMOD	O
O	O	1229	1238	regulated	regulate	I-VP	VBN	O	25	VC	O
O	O	1239	1241	by	by	B-PP	IN	O	30	VMOD	O
O	O	1242	1245	PAO	PAO	B-NP	NN	O	31	PMOD	O
O	O	1246	1248	in	in	B-PP	IN	O	30	VMOD	O
O	O	1249	1250	a	a	B-NP	DT	O	38	NMOD	O
O	O	1251	1255	dose	dose	I-NP	NN	O	38	NMOD	O
O	O	1255	1256	-	-	B-NP	HYPH	O	38	NMOD	O
O	O	1256	1265	dependent	dependent	I-NP	JJ	O	38	NMOD	O
O	O	1266	1272	manner	manner	I-NP	NN	O	33	PMOD	O
O	O	1272	1273	.	.	O	.	O	2	P	O

O	O	1274	1277	PAO	PAO	B-NP	NN	O	2	SUB	O
O	O	1278	1281	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1282	1287	found	find	I-VP	VBN	O	2	VC	O
O	O	1288	1290	to	to	I-VP	TO	O	5	VMOD	O
O	O	1291	1293	be	be	I-VP	VB	O	3	VMOD	O
O	O	1294	1303	effective	effective	B-ADJP	JJ	O	5	PRD	O
O	O	1304	1308	even	even	B-ADVP	RB	O	8	AMOD	O
O	O	1309	1313	when	when	I-ADVP	WRB	O	2	VMOD	O
O	O	1314	1319	added	add	B-VP	VBN	O	8	SBAR	O
O	O	1320	1321	3	3	B-NP	CD	O	11	NMOD	O
O	O	1322	1323	h	h	I-NP	NN	O	12	PMOD	O
O	O	1324	1329	after	after	B-PP	IN	O	9	VMOD	O
O	O	1330	1333	TNF	TNF	B-NP	NN	B-protein	12	PMOD	B-protein
O	O	1333	1334	,	,	O	,	O	2	P	O
O	O	1335	1345	suggesting	suggest	B-VP	VBG	O	2	VMOD	O
O	O	1346	1347	a	a	B-NP	DT	O	18	NMOD	O
O	O	1348	1353	rapid	rapid	I-NP	JJ	O	18	NMOD	O
O	O	1354	1358	mode	mode	I-NP	NN	O	15	OBJ	O
O	O	1359	1361	of	of	B-PP	IN	O	18	NMOD	O
O	O	1362	1368	action	action	B-NP	NN	O	19	PMOD	O
O	O	1369	1371	of	of	B-PP	IN	O	20	NMOD	O
O	O	1372	1376	this	this	B-NP	DT	O	23	NMOD	O
O	O	1377	1386	inhibitor	inhibitor	I-NP	NN	O	21	PMOD	O
O	O	1386	1387	.	.	O	.	O	2	P	O

O	O	1388	1395	Besides	Besides	B-PP	IN	O	15	VMOD	O
O	O	1396	1399	PAO	PAO	B-NP	NN	O	1	PMOD	O
O	O	1399	1400	,	,	O	,	O	15	P	O
O	O	1401	1406	other	other	B-NP	JJ	O	5	NMOD	O
O	O	1407	1417	inhibitors	inhibitor	I-NP	NNS	O	15	SUB	O
O	O	1418	1420	of	of	B-PP	IN	O	5	NMOD	O
O	O	1421	1427	PTPase	PTPase	B-NP	NN	B-protein	6	PMOD	B-protein
O	O	1427	1428	,	,	O	,	O	5	P	O
O	O	1429	1438	including	include	B-PP	VBG	O	5	NMOD	O
O	O	1439	1450	pervanadate	pervanadate	B-NP	NN	O	12	NMOD	O
O	O	1451	1454	and	and	I-NP	CC	O	12	NMOD	O
O	O	1455	1462	diamide	diamide	I-NP	NN	O	9	PMOD	O
O	O	1462	1463	,	,	O	,	O	5	P	O
O	O	1464	1468	also	also	B-ADVP	RB	O	15	VMOD	O
O	O	1469	1476	blocked	block	B-VP	VBD	O	0	ROOT	O
O	O	1477	1480	TNF	TNF	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	1480	1481	-	-	O	HYPH	O	23	NMOD	O
O	O	1481	1490	dependent	dependent	B-NP	JJ	O	23	NMOD	O
T15	B-Entity	1491	1493	NF	NF	I-NP	NN	B-protein	22	NMOD	B-protein
T15	I-Entity	1493	1494	-	-	B-NP	HYPH	I-protein	22	NMOD	I-protein
T15	I-Entity	1494	1499	kappa	kappa	I-NP	NN	I-protein	22	NMOD	I-protein
T15	I-Entity	1500	1501	B	B	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	1502	1512	activation	activation	I-NP	NN	O	25	NMOD	O
O	O	1513	1516	and	and	O	CC	O	25	NMOD	O
O	O	1517	1526	induction	induction	B-NP	NN	O	15	OBJ	O
O	O	1527	1529	of	of	B-PP	IN	O	25	NMOD	O
O	O	1530	1533	all	all	B-NP	PDT	O	29	NMOD	O
O	O	1534	1537	the	the	I-NP	DT	O	29	NMOD	O
O	O	1538	1543	three	three	I-NP	CD	O	26	PMOD	O
O	O	1544	1552	adhesion	adhesion	I-NP	NN	B-protein	31	NMOD	B-protein
O	O	1553	1561	proteins	protein	I-NP	NNS	I-protein	29	NMOD	I-protein
O	O	1561	1562	.	.	O	.	O	15	P	O

O	O	1563	1573	Consistent	Consistent	B-ADJP	JJ	O	12	VMOD	O
O	O	1574	1578	with	with	B-PP	IN	O	1	AMOD	O
O	O	1579	1584	these	these	B-NP	DT	O	4	NMOD	O
O	O	1585	1592	results	result	I-NP	NNS	O	2	PMOD	O
O	O	1592	1593	,	,	O	,	O	12	P	O
O	O	1594	1597	the	the	B-NP	DT	O	7	NMOD	O
O	O	1598	1608	attachment	attachment	I-NP	NN	O	12	SUB	O
O	O	1609	1611	of	of	B-PP	IN	O	7	NMOD	O
O	O	1612	1621	monocytes	monocyte	B-NP	NNS	B-cell_type	8	PMOD	B-cell_type
O	O	1622	1624	to	to	B-PP	TO	O	7	NMOD	O
O	O	1625	1629	MVEC	MVEC	B-NP	NNS	B-cell_line	10	PMOD	B-cell_line
O	O	1630	1633	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1634	1638	also	also	I-VP	RB	O	12	VMOD	O
O	O	1639	1646	blocked	block	I-VP	VBN	O	12	VC	O
O	O	1647	1649	by	by	B-PP	IN	O	14	VMOD	O
O	O	1650	1653	the	the	B-NP	DT	O	18	NMOD	O
O	O	1654	1660	PTPase	PTPase	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	1661	1671	inhibitors	inhibitor	I-NP	NNS	O	15	PMOD	O
O	O	1671	1672	.	.	O	.	O	12	P	O

O	O	1673	1677	Thus	Thus	B-ADVP	RB	O	7	VMOD	O
O	O	1677	1678	,	,	O	,	O	7	P	O
O	O	1679	1686	overall	overall	B-ADVP	RB	O	7	VMOD	O
O	O	1686	1687	,	,	O	,	O	7	P	O
O	O	1688	1691	our	our	B-NP	PRP$	O	6	NMOD	O
O	O	1692	1699	results	result	I-NP	NNS	O	7	SUB	O
O	O	1700	1711	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	1712	1716	that	that	B-SBAR	IN	O	7	VMOD	O
O	O	1717	1718	a	a	B-NP	DT	O	10	NMOD	O
O	O	1719	1725	PTPase	PTPase	I-NP	NN	B-protein	11	SUB	B-protein
O	O	1726	1728	is	be	B-VP	VBZ	O	8	SBAR	O
O	O	1729	1737	involved	involve	I-VP	VBN	O	11	VC	O
O	O	1738	1744	either	either	O	CC	O	14	AMOD	O
O	O	1745	1753	directly	directly	B-VP	RB	O	12	VMOD	O
O	O	1754	1756	or	or	I-VP	CC	O	14	AMOD	O
O	O	1757	1767	indirectly	indirectly	I-VP	RB	O	14	AMOD	O
O	O	1768	1770	in	in	B-PP	IN	O	12	VMOD	O
O	O	1771	1774	the	the	B-NP	DT	O	19	NMOD	O
O	O	1775	1782	pathway	pathway	I-NP	NN	O	17	PMOD	O
O	O	1783	1790	leading	lead	B-VP	VBG	O	19	NMOD	O
O	O	1791	1793	to	to	B-PP	TO	O	20	VMOD	O
O	O	1794	1797	the	the	B-NP	DT	O	23	NMOD	O
O	O	1798	1807	induction	induction	I-NP	NN	O	21	PMOD	O
O	O	1808	1810	of	of	B-PP	IN	O	23	NMOD	O
O	O	1811	1822	endothelial	endothelial	B-NP	JJ	B-protein	28	NMOD	B-protein
O	O	1823	1827	cell	cell	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	1828	1836	adhesion	adhesion	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	1837	1846	molecules	molecule	I-NP	NNS	I-protein	24	PMOD	I-protein
O	O	1847	1849	by	by	B-PP	IN	O	23	NMOD	O
O	O	1850	1853	TNF	TNF	B-NP	NN	B-protein	29	PMOD	B-protein
O	O	1853	1854	.	.	O	.	O	7	P	O

O	O	1855	1862	Because	Because	B-PP	IN	O	10	VMOD	O
O	O	1863	1865	of	of	I-PP	IN	O	1	PMOD	O
O	O	1866	1871	their	their	B-NP	PRP$	O	4	NMOD	O
O	O	1872	1876	role	role	I-NP	NN	O	2	PMOD	O
O	O	1877	1879	in	in	B-PP	IN	O	4	NMOD	O
O	O	1880	1884	cell	cell	B-NP	NN	O	7	NMOD	O
O	O	1885	1893	adhesion	adhesion	I-NP	NN	O	5	PMOD	O
O	O	1893	1894	,	,	O	,	O	10	P	O
O	O	1895	1901	PTPase	PTPase	B-NP	NN	B-protein	10	SUB	B-protein
O	O	1902	1905	may	may	B-VP	MD	O	0	ROOT	O
O	O	1906	1913	provide	provide	I-VP	VB	O	10	VC	O
O	O	1914	1915	a	a	B-NP	DT	O	14	NMOD	O
O	O	1916	1921	novel	novel	I-NP	JJ	O	14	NMOD	O
O	O	1922	1928	target	target	I-NP	NN	O	11	OBJ	O
O	O	1929	1931	of	of	B-PP	IN	O	14	NMOD	O
O	O	1932	1936	drug	drug	B-NP	NN	O	17	NMOD	O
O	O	1937	1948	development	development	I-NP	NN	O	15	PMOD	O
O	O	1949	1952	for	for	B-PP	IN	O	14	NMOD	O
O	O	1953	1962	treatment	treatment	B-NP	NN	O	18	PMOD	O
O	O	1963	1965	of	of	B-PP	IN	O	19	NMOD	O
O	O	1966	1978	inflammation	inflammation	B-NP	NN	O	27	NMOD	O
O	O	1978	1979	,	,	O	,	O	27	P	O
O	O	1980	1993	atherogenesis	atherogenesis	B-NP	NN	O	27	NMOD	O
O	O	1993	1994	,	,	O	,	O	27	P	O
O	O	1995	1998	and	and	O	CC	O	27	NMOD	O
O	O	1999	2004	tumor	tumor	B-NP	NN	O	27	NMOD	O
O	O	2005	2015	metastasis	metastasis	I-NP	NN	O	20	PMOD	O
O	O	2015	2016	.	.	O	.	O	10	P	O
